Home Cart 0 Sign in  
X

[ CAS No. 733039-20-8 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 733039-20-8
Chemical Structure| 733039-20-8
Chemical Structure| 733039-20-8
Structure of 733039-20-8 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 733039-20-8 ]

Related Doc. of [ 733039-20-8 ]

Alternatived Products of [ 733039-20-8 ]

Product Details of [ 733039-20-8 ]

CAS No. :733039-20-8 MDL No. :MFCD13181206
Formula : C9H11BrClN3 Boiling Point : -
Linear Structure Formula :- InChI Key :DIVUXBABVYOIOT-UHFFFAOYSA-N
M.W : 276.56 Pubchem ID :44248247
Synonyms :

Calculated chemistry of [ 733039-20-8 ]

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.56
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 61.16
TPSA : 37.81 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.54 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.79
Log Po/w (XLOGP3) : 3.44
Log Po/w (WLOGP) : 3.06
Log Po/w (MLOGP) : 1.93
Log Po/w (SILICOS-IT) : 2.84
Consensus Log Po/w : 2.81

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.91
Solubility : 0.0343 mg/ml ; 0.000124 mol/l
Class : Soluble
Log S (Ali) : -3.91
Solubility : 0.0336 mg/ml ; 0.000122 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.33
Solubility : 0.013 mg/ml ; 0.000047 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.07

Safety of [ 733039-20-8 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338-P310 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 733039-20-8 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 733039-20-8 ]
  • Downstream synthetic route of [ 733039-20-8 ]

[ 733039-20-8 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 733039-20-8 ]
  • [ 571188-82-4 ]
Reference: [1] Patent: WO2014/128588, 2014, A1,
[2] Patent: WO2016/30439, 2016, A1,
[3] Organic Process Research and Development, 2016, vol. 20, # 7, p. 1191 - 1202
[4] Patent: CN104447739, 2016, B,
  • 2
  • [ 36082-50-5 ]
  • [ 1003-03-8 ]
  • [ 733039-20-8 ]
YieldReaction ConditionsOperation in experiment
100% at 20℃; for 6 h; To a solution of 5-bromo-2,4- dichloropyrimidine (45.6 g, 200 mmol) in dioxane (400 mL) was added N-cyclopentylamine (20.4 g, 240 mmol) at room temperature. The mixture thus obtained was stirred at room temperature for 6 h. The reaction mixture was then diluted with ethyl acetate and washed with brine and dried over MgSO4. The solvent was evaporated to give the title compound as a light yellow solid (56 g, 100percent) which was used in next step without further purification. 1H νMR (500 MHz, DMSO-d6) δ 8.23 (IH, s), 7.37 (IH, <n="37"/>d, J=7.3 Hz), 4.31 (IH, m), 1.92 (2H, m), 1.71 (2H, m), 1.53-1.59 (4H, m) ppm; LCMS-ESI (POS), M/Z, M+l: Found 276.0, Calculated 275.9.
90% With N-ethyl-N,N-diisopropylamine In ethanol at 10 - 40℃; for 5 h; Inert atmosphere A solution of 5-bromo-2,4-dichloropyrimidine(1) (5 g, 22 mmol) and N,N-diisopropylethylamine (5.7g, 44 mmol) in ethanol (30 mL) was cooled to 10°C under nitrogenatmosphere. Charged cyclopentylamine (2.1g, 24.1 mmol)and stirred for 5 hours at 40°C. Progress of the reaction wasmonitored by TLC and solvent was evaporated undervacuum. Resulting residue was stirred with hexane (20 mL)for 2 hours at 0°C. Precipitate was filtered and washed withhexane to obtain compound (2). Off-white crystalline solid,Yield: 90percent, mp. 95-97 °C. 1H NMR (400 MHz, DMSO-d6):1.57-1.62 (m, 4H, -CH2-CH2-), 1.64-1.69 (m, 2H, CH2),1.87-1.93 (m, 2H, CH2), 4.27-4.33 (m, 1H, -NH-CH-), 7.35(d, 1H, J=7.44 Hz, -NH), 8.20 (s, 1H, Ar-H). 13C NMR(75.46 MHz, DMSO-d6): 159.4, 158.6, 157.1, 102.9, 53.0,31.8, 24.0. ESI-HRMS (m/z): Calcd. for C9H11BrClN3:276.5614. Found: m/z 277.2618 [M+H]+.
89% With N-ethyl-N,N-diisopropylamine In ethanol at 20℃; In a large sealed tube is added 5-bromo-2,4-dichloropyrimidine (3g, 13.2 mmol) in 100 mL of EtOH. Then cyclopentyl amine (1.95 mL, 19.75 mmol) andN,N'-diisopropylethylamine (3.36 mL, 19.8 mmol) are added to the solution at rt. The solution is then stirred rt overnight. Solvent is evaporated and the crude is purified using silica gel chromatography (15percent ethyl acetate/85percenthexane) to give (5- bromo-2-chloro-pyrimidin-4-yl)-cyclopentyl-amine as a white solid (3.25g, 89percent). MS(ESI) m/z 278.4 (M+H)+
88% With N-ethyl-N,N-diisopropylamine In ethyl acetate at 18 - 40℃; for 7 h; Inert atmosphere A nitrogen-flushed, suitably equipped 5 L 4-neck round bottom flask is charged with 250 g (1.097 mol, 140.4 mL, 1.0 eq.) of 5-bromo-2,4-dichloropyrimidine (A1h) and 1127 g, (1250 mL) of ethyl acetate.
The content is stirred at 20° C. and 283.5 g (2.194 mol, 382.0 mL, 2.0 eq.) of N,N-diisopropylethylamine is added.
A solution of 102.8 g (1.207 mol, 119 mL, 1.1 eq.) of cyclopentylamine (A1g) dissolved in 1127 g, (1250 mL) of ethyl acetate is added over 60 min.
An 18° C. to 36° C. exotherm is observed.
The solution is warmed to 40° C.
This temperature is maintained for at least 6 h or until all the starting material A1h, is consumed as determined by HPLC analysis.
The resulting slurry is cooled to 25° C. and 500 g (500 mL) of water is added.
The content is stirred for 15 min and the phases are allowed to separate.
The bottom (aqueous) layer is removed and the organic layer is washed once more with 500 g (500 mL) of water.
The sample is stirred for 15 min, and the phases are allowed to separate.
The bottom (aqueous) layer is removed.
The organic phase is concentrated (atmospheric pressure) to a volume of 1500 mL (batch temp=82° C.).
684 g (1 L) of heptane is added and the concentration is resumed to a volume of 1500 mL (batch temp=85° C.).
Again, 684 g (1 L) of heptane is added and the concentration is resumed to a volume of 1500 mL (batch temp=96° C.).
The sample is cooled to 50° C. and seeded.
The cooling is continued to 4° C. and the temperature is maintained at 4° C. for 1 h.
The solids are filtered and the filter cake is washed once with 137 g (200 mL) of cold (4° C.) heptane.
The solids are dried at 50° C. for 16 h, to afford 259.0 g (88.0percent, corrected) of Compound A1f as a white, crystalline solid, mp=95-96° C.
87.2% at 10 - 20℃; for 3 h; Step i): synthesis of (5-Bromo-2-chloro-pyrimidin-4-yl)-cyclopentyl-amine (formula 13)Step i: A 4 L 3-necked RBF, equipped with a 500 ml addition funnel, was charged with 250.0 g of 5-Bromo-2,4-dichloro-pyrimidine (1 .097 mol, 1 .00 eq.) and 880 ml absolute EtOH. The mixture was cooled to 10°C with an ice-bath A solution of 250 ml cyclopentylamine (130 mmol, 1 .18 eq.) in 250 ml absolute EtOH was added dropwise over 60 min while maintaining the temperature between 10-15°C After stirring for 1 h, the mixture was allowed to warm up to RT and further stirred for 1 h. The reaction was quenched with 1 .1 L water then seeding material was added. After stirring at RT for 2 h, the precipitated solid was collected by filtration, washed with 1 L water/EtOH (8/2) acetonitrile and left in air at RT to give crude wet (5-Bromo-2-chloro-pyrimidin-4-yl)- cyclopentyl-amine as white solid.HPLC (Method 1 ): 9.67 min (89.3percent) (254 nm).Crude product was suspended in 1 .5 L hexane and heated to reflux for 45 min. Resulting slurry was allowed to cool down slowly to RT with stirring. After 3 h, stirring was stopped and the mixture left at RT. Solid was collected by filtration, washed with hexane (350 ml), dried in air for 10 min then at 50^/35 mbar for 2 h to give 264.51 g of purified (5-Bromo-2-chloro-pyrimidin-4-yl)-cyclopentyl-amine (87.2percent yield) as white solid.HPLC (Method 1 ): 10.02 min (99.7percent) (254 nm).
85% at 25℃; for 2 h; EXAMPLE 3: Preparation of 2-Chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one; Example 3A: Preparation of S-bromo^-chloro^-cyclopentyl-aminopyrimidineTo -1 -g (0.004 mol) of 5-bromo-2,4-dichloropyrimidine in ethanol was added 1.5 kg (0.018 mol) cyclopentylamine under nitrogen. The mixture was stirred at 25°C for 2hrs. Water was added to precipitate the product, and the solid was recrystallized using hexane 4:1 to give a white crystalline product (3A).
84% With triethylamine In ethanol at 25℃; for 4 h; To a vessel was added absolute ethanol (3000 mL, 3.0 vol) followed by 5-bromo-2,4- dichloropyrimidine (mw 227.87; 1000 g, 1.0 equiv.). Triethylamine (612 mL, 1.0 equiv.) was added, and then cyclopentylamine (mw 85.15; 520 mL, 1.2 equiv.) was added slowly over 2 hours to control the mild exotherm. After completion of cyclopentylamine addition, the reaction was seeded with 5-bromo-2-chloro-6-cyclopentylamino-pyrimidine (5 g, 0.5 wtpercent) to induce crystallization, if needed. The reaction was stirred at 25°C for 2 hours.Water (2500 mL, 2.5 vol) was added to the vessel at 20-25 °C at a rate of 30 mL/min. The mixture was cooled to 8-12°C at 2°C/min. The slurry was kept at 8-12°C for 1 hour and then filtered onto a 2 Whatman™ paper filter. The cake was rinsed with n-heptane (2000 mL). The cake was reslurried with n-heptane on the filter drier (2000 mL). The material was dried overnight in the vacuum oven at 50-55°C to give 5-bromo-2-chloro-6-cyclopentylamino- pyrimidine (1020 g; 84percent) as a white solid.
80% With triethylamine In dichloromethane at 0 - 45℃; for 6 h; Add 5-bromo-2,4-dichloropyrimidine (IV-1) (11.4 g, 50 mmol) to the reaction flask.Triethylamine (2.24 g, 20 mmol) and methylene chloride (150 mL) were stirred and cooled to 0-5 °C.Cyclopentylamine (V) (4.257 g, 50 mmol) was slowly added dropwise. After the addition was complete, the reaction was heated to 45° C. for 6 hours.TLC detection reaction is complete. At the end of the reaction, 150 mL of quenched water was added.The organic phase is washed twice with saturated saline solution.The aqueous phase is extracted twice with ethyl acetate,Combine the organic phase,Drying with anhydrous sodium sulfate,Distillation under reduced pressure to recover the solventThe resulting concentrate was purified by column chromatography using a mixture of petroleum ether and ethyl acetate to give 2-chloro-4-cyclopentylamino-5-bromopyrimidine (VI-1) (11.0 g).Yield 80percent; Purity 99.8percent
80% With triethylamine In dichloromethane at 0 - 45℃; for 6 h; To the reaction flask was added 5-bromo-2,4-dichloropyrimidine (I) (11.4 g, 50 mmol), triethylamine (2.24 g, 20 mmol)Dichloromethane (150 mL) was added and the mixture was stirred and cooled to 0-5°C. Cyclopentylamine (II) (4.257 g, 50 mmol) was slowly added dropwise. After the addition was complete, the temperature was raised to 45° C. for 6 hours. TLC reaction was completed. . At the end of the reaction, 150 mL of water was quenched, the organic phase was washed twice with saturated brine, and the aqueous phase was extracted twice with ethyl acetate. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The resulting concentrate was used with petroleum ether and The compound 2-chloro-4-cyclopentylamino-5-bromopyrimidine (III-1) was isolated by column chromatography of ethyl acetate mixed solvent to give 11.0 g; the yield was 80percent; the purity was 99.8percent (HPLC area normalization method).
74% With triethylamine In tetrahydrofuran at 0 - 20℃; 5-BROMO-2, 4-dichloro-pyrimidine (18.21 g, 79.9 mmol) was dissolved in THE and place in a 0°C ice bath. Triethylamine (23.77 g, 235 mmol) was added. Reaction became light yellow. Following this, cyclopentyl amine (3.67 g, 78.31 mmol) was added. The ice bath was removed and the reaction was stirred overnight. Reaction was filtered and concentrated. Purified on silica gel using 20: 1 Hexane/EtOAc to afford 16.09 g (74percent) of (5-BROMO-2-CHLORO-PYRIMIDIN-4- yl) -cyclopentyl-amine.
8 g With triethylamine In ethanol for 2 h; 7gcyclopentaneamine (Compound 5b) was dissolved in 100ml of absolute ethanol.16ml of Et3N was added. Under stirring conditions, 9g2,4-dichloro-5-bromopyrimidine (Compound 5a) was added portionwise to thesystem. The reaction was continued after addition for 2h. After completion ofthe reaction, the system was filtered, and the filtrate was concentrated. Waterwas added to precipitate a white solid, to which was added a small amount ofpetroleum ether. After stirred for 10 minutes, the system was filtered to give8g white solid as Compound 14.

Reference: [1] Patent: WO2009/85185, 2009, A1, . Location in patent: Page/Page column 35
[2] Journal of Medicinal Chemistry, 2014, vol. 57, # 8, p. 3430 - 3449
[3] Combinatorial Chemistry and High Throughput Screening, 2017, vol. 20, # 8, p. 703 - 712
[4] Patent: WO2010/20675, 2010, A1, . Location in patent: Page/Page column 89
[5] Patent: US2012/115878, 2012, A1, . Location in patent: Page/Page column 5-6
[6] Patent: WO2016/30439, 2016, A1, . Location in patent: Page/Page column 30; 31
[7] Patent: WO2008/32157, 2008, A2, . Location in patent: Page/Page column 26
[8] Patent: WO2014/128588, 2014, A1, . Location in patent: Page/Page column 34
[9] Organic Process Research and Development, 2016, vol. 20, # 7, p. 1191 - 1202
[10] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 12, p. 4033 - 4037
[11] Patent: CN107759596, 2018, A, . Location in patent: Paragraph 0054; 0055
[12] Patent: CN107936029, 2018, A, . Location in patent: Paragraph 0047; 0050-0052; 0065; 0082
[13] Patent: WO2004/65378, 2004, A1, . Location in patent: Page 55
[14] European Journal of Medicinal Chemistry, 2015, vol. 95, p. 174 - 184
[15] Patent: CN104447739, 2016, B, . Location in patent: Paragraph 0141; 0143; 0144
  • 3
  • [ 733039-20-8 ]
  • [ 107-93-7 ]
  • [ 1013916-37-4 ]
YieldReaction ConditionsOperation in experiment
81%
Stage #1: With palladium diacetate; triethylamine In 1-methyl-pyrrolidin-2-one at 65℃; Inert atmosphere
Stage #2: With acetic anhydride In 1-methyl-pyrrolidin-2-one at 65℃; Inert atmosphere
To a vessel was added 5-bromo-2-chloro-6-cyclopentylamino-pyridimidine (10.0 g, 1.0 equiv.) along with N-methylpyrrolidone (NMP) (50 mL, 5.0 vol.) at ambient temperature. To the reaction mixture was added crotonic acid (4.7 g, 1.5 equiv.) and triethylamine (20.2 mL, 4.0 equiv.). The vessel was degassed and purged three times with nitrogen. To the degassed reaction mixture was added Pd(OAc)2(0.25 g, 0.03 equiv.). The vessel was degassed and purged three times with nitrogen using the same method as step 3. The mixture was heated to 65°C and allowed to stir until starting material was consumed (at least 6 hours).Acetic anhydride (6.8 mL, 2.0 equiv) was added to the reaction mixture. The reaction was allowed to react at 65 °C until starting material was consumed (usually 1-2 hours). The reaction mixture was cooled to 20°C and H20 (100 mL, 10 vol) was added to dissolve triethylamine-HBr salts and precipitate out 2-chloro-8-cyclopentyl-5-methyl-8/-/- pyrido[2,3-c]pyrimidin-7-one. The material was granulated at 20 °C for 1 hour. The solids were filtered and washed with H20 (20 mL, 2.0 vol), and a 4: 1 mixture of isopropanol/H20 (50 mL, 5.0 vol). The crude product was dried under vacuum at 55-70°C to give 2-chloro-8-cyclopentyl-5- methyl-8/-/-pyrido[2,3-c]pyrimidin-7-one, (7.8 g; 81 percent) as a tan to gray solid.
68%
Stage #1: With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 70℃; for 16 h;
Stage #2: With acetic anhydride In tetrahydrofuran for 1.5 h;
Example 3: Preparation of 2-Chloro-8-Cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one 41.5 g (0.15 mol) of δ-bromo^-chlorcMl-cyclopentylaminopyrimidine 3a and 32.3g (0.375 mol) of crotonic acid were mixed in 100L of THF and 105ml (1.6 mol) diisopropyl ethylamine under nitrogen. The slurry was stirred, evacuated and refilled with nitrogen three times, after which 860mg (0.0022 mol) palladium dichloride dibenzonitrile complex and 685mg(0.0022mol) tri-ortho-tolylphosphine were added and the resulting slurry degassed an additional three times. The mixture was then heated and stirred at 700C for 16hrs, after which 35 ml acetic anhydride was added and the mixture stirred for an additional 1.5hrs. The mixture was cooled and diluted with 100ml MTBE and then extracted with 1NHCI, then aqueous sodium bicarbonate and brine. The organic phase was dried over magnesium sulfate, filtered, concentrated in vacuo, and recrystallized from IPA to yield 31.2 g {68percent) of crude product {3).
Reference: [1] Patent: WO2014/128588, 2014, A1, . Location in patent: Page/Page column 34; 35
[2] Patent: WO2008/32157, 2008, A2, . Location in patent: Page/Page column 26
  • 4
  • [ 3724-65-0 ]
  • [ 733039-20-8 ]
  • [ 1013916-37-4 ]
YieldReaction ConditionsOperation in experiment
94.8% With triethylamine; palladium dichloride In 1-methyl-pyrrolidin-2-one at 20 - 75℃; for 6 h; Inert atmosphere Compound 2 (10.0 g, 36.2 mmol, 1.0 eq) was added at room temperature.N-methylpyrrolidone (NMP, 50 mL),Crotonic acid (4.7 g, 54.6 mmol, 1.5 eq) and triethylamine (14.7 g, 144.9 mol, 4.0 eq).The container is passed through three times of nitrogen,PdCl 2 (0.195 g, 1.10 mmol, 0.03 eq) was added to the exhausted reaction mixture.Three more nitrogen passes.After the raw materials are stirred and dissolved at room temperature,Rapidly warm up to 75 ° C,The stirring reaction was closed for 6 h,Sampling (diluted with ethyl acetate),TLC detection (DCM: MeOH = 12:1),The starting compound 1 is completely reacted,Add acetic anhydride to react 0.5h sampling point plate,The intermediate reaction is complete,The reaction mixture will be brought to 20 ° C,Add triethylamine hydrobromide solution (100 mL),Stir for 1h,Filtering,Water washing,Get a gray solid. Add ethyl acetate to dissolve,Add anhydrous magnesium sulfate to dry the mixture,Insoluble matter (salt and insoluble catalyst) is filtered out,Wash with ethyl acetate.Concentrate the filtrate to a low volume,Add n-hexane,Beating at 65 ° C for 30 min,Cool to 20 ° C and stir for 1 h.Filtering the solid,Vacuum drying,Obtained a brownish yellow solid,That is, Compound 1 (9.04 g, yield 94.8percent, purity 99.1percent).
80%
Stage #1: With bis(benzonitrile)palladium(II) dichloride; N-ethyl-N,N-diisopropylamine; tris-(o-tolyl)phosphine In tetrahydrofuran at 75℃; for 20 h; Inert atmosphere
Stage #2: at 75℃; for 2 h;
Step ii): synthesis of 2-Chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin- 7-one formula 15)Step ii): A 1 L 3-necked RBF was charged with 50.0 g of (5-Bromo-2-chloro-pyrimidin- 4-yl)-cyclopentyl-amine (0.181 mol, 1 .00 eq.), 39.0 g crotonic acid (0.452 mol, 2.5 eq.), 125 ml diisopropylethylamine (0.741 mol, 4.1 eq.) and 125 ml THF. The mixture was degassed by applying 3 vacuum/argon cycles then 1 .10 g of tri-o-tolyl-phosphine (3.62 mmol, 0.02 eq.) and 1 .39 g dichlorobis(benzonitrile)palladium(ll) (3.62 mmol, 0.02 eq.) were added. The mixture was degassed again by applying 3 vacuum/argon cycles then heated to 75°C and stirred under argon for 20 h. Then, 43.0 ml of acetic anhydride (0.452 mol, 2.5 eq.) were added and the mixture further stirred at 75^ for 2 h. The reaction was quenched with 250 ml water and the mixture allowed to cool down to RT. After 1 h stirring, 125 ml water was added while cooling to Ι δ'. The precipitated solid was collected by filtration, washed with water (125 ml), cold isopropanol (3 x 125 ml), dried in air for 10 min then at 50<€/25 mbar for 20 h to give 38.13 g of 2-Chloro-8- cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one (formula 15) (80.0percent yield) as yellowish solid. HPLC (Method 1 ): 8.67 min (99.6percent) (254 nm).1H NMR (400 MHz, CDCI3, δ ppm): 1 .68 (br. s, 2 H), 1 .84 - 1 .98 (m, 2 H), 2.12 (br. s, 2 H), 2.22 (br. s, 2 H), 2.44 (s, 3 H), 5.84 (m, 1 H), 6.53 (br. s, 1 H), 8.74 (s, 1 H).
Reference: [1] Patent: CN108117550, 2018, A, . Location in patent: Paragraph 0029; 0030, 0031; 0034; 0036; 0037
[2] Patent: WO2016/30439, 2016, A1, . Location in patent: Page/Page column 31; 32
  • 5
  • [ 733039-20-8 ]
  • [ 18269-64-2 ]
  • [ 1013916-37-4 ]
Reference: [1] Patent: WO2016/16769, 2016, A1, . Location in patent: Page/Page column 9; 10
  • 6
  • [ 733039-20-8 ]
  • [ 1013916-37-4 ]
Reference: [1] Organic Process Research and Development, 2016, vol. 20, # 7, p. 1191 - 1202
[2] Patent: CN104447739, 2016, B,
  • 7
  • [ 733039-20-8 ]
  • [ 1211443-61-6 ]
Reference: [1] Patent: US2012/115878, 2012, A1,
[2] Patent: CN106478641, 2017, A,
[3] Patent: CN107936029, 2018, A,
  • 8
  • [ 733039-20-8 ]
  • [ 1211443-58-1 ]
Reference: [1] Patent: CN106478641, 2017, A,
[2] Patent: CN108586356, 2018, A,
  • 9
  • [ 733039-20-8 ]
  • [ 1374639-77-6 ]
Reference: [1] Patent: US2012/115878, 2012, A1,
[2] Combinatorial Chemistry and High Throughput Screening, 2017, vol. 20, # 8, p. 703 - 712
Same Skeleton Products
Historical Records

Pharmaceutical Intermediates of
[ 733039-20-8 ]

Palbociclib Related Intermediates

Chemical Structure| 39856-50-3

[ 39856-50-3 ]

5-Bromo-2-nitropyridine

Chemical Structure| 571188-82-4

[ 571188-82-4 ]

tert-Butyl 4-(6-((6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate

Chemical Structure| 867-13-0

[ 867-13-0 ]

Ethyl 2-(diethoxyphosphoryl)acetate

Chemical Structure| 571189-16-7

[ 571189-16-7 ]

tert-Butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate

Chemical Structure| 571188-59-5

[ 571188-59-5 ]

tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate

Ribociclib Intermediates

Chemical Structure| 52092-47-4

[ 52092-47-4 ]

5-Chloro-2-nitropyridine

Chemical Structure| 1374639-77-6

[ 1374639-77-6 ]

(2-Chloro-7-cyclopentyl-7H-pyrrolo[2,3-d]pyrimidin-6-yl)methanol

Chemical Structure| 1211443-61-6

[ 1211443-61-6 ]

2-Chloro-7-cyclopentyl-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide

Chemical Structure| 571189-16-7

[ 571189-16-7 ]

tert-Butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate

Chemical Structure| 571188-59-5

[ 571188-59-5 ]

tert-Butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate

Related Functional Groups of
[ 733039-20-8 ]

Bromides

Chemical Structure| 32779-36-5

[ 32779-36-5 ]

5-Bromo-2-chloropyrimidine

Similarity: 0.63

Chemical Structure| 1060816-58-1

[ 1060816-58-1 ]

5-Bromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.63

Chemical Structure| 633328-95-7

[ 633328-95-7 ]

5-Bromo-2-chloro-4-methylpyrimidine

Similarity: 0.61

Chemical Structure| 205672-25-9

[ 205672-25-9 ]

4-Amino-5-bromo-2-chloropyrimidine

Similarity: 0.58

Chemical Structure| 77476-95-0

[ 77476-95-0 ]

(5-Bromopyrimidin-2-yl)isopropylamine

Similarity: 0.56

Chlorides

Chemical Structure| 32779-36-5

[ 32779-36-5 ]

5-Bromo-2-chloropyrimidine

Similarity: 0.63

Chemical Structure| 1060816-58-1

[ 1060816-58-1 ]

5-Bromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.63

Chemical Structure| 633328-95-7

[ 633328-95-7 ]

5-Bromo-2-chloro-4-methylpyrimidine

Similarity: 0.61

Chemical Structure| 205672-25-9

[ 205672-25-9 ]

4-Amino-5-bromo-2-chloropyrimidine

Similarity: 0.58

Chemical Structure| 335654-06-3

[ 335654-06-3 ]

2-Chloro-7H-pyrrolo[2,3-d]pyrimidine

Similarity: 0.58

Amines

Chemical Structure| 205672-25-9

[ 205672-25-9 ]

4-Amino-5-bromo-2-chloropyrimidine

Similarity: 0.58

Chemical Structure| 64376-18-7

[ 64376-18-7 ]

6-Amino-2-chloropyrimidine-4-carbonitrile

Similarity: 0.58

Chemical Structure| 77476-95-0

[ 77476-95-0 ]

(5-Bromopyrimidin-2-yl)isopropylamine

Similarity: 0.56

Chemical Structure| 956100-62-2

[ 956100-62-2 ]

8-Bromo-2-chloroquinazolin-4-amine

Similarity: 0.56

Chemical Structure| 89180-51-8

[ 89180-51-8 ]

2,5-Dichloropyrimidin-4-amine

Similarity: 0.54

Related Parent Nucleus of
[ 733039-20-8 ]

Pyrimidines

Chemical Structure| 32779-36-5

[ 32779-36-5 ]

5-Bromo-2-chloropyrimidine

Similarity: 0.63

Chemical Structure| 633328-95-7

[ 633328-95-7 ]

5-Bromo-2-chloro-4-methylpyrimidine

Similarity: 0.61

Chemical Structure| 205672-25-9

[ 205672-25-9 ]

4-Amino-5-bromo-2-chloropyrimidine

Similarity: 0.58

Chemical Structure| 64376-18-7

[ 64376-18-7 ]

6-Amino-2-chloropyrimidine-4-carbonitrile

Similarity: 0.58

Chemical Structure| 77476-95-0

[ 77476-95-0 ]

(5-Bromopyrimidin-2-yl)isopropylamine

Similarity: 0.56